562 related articles for article (PubMed ID: 16166439)
21. Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease.
Lazar AD; Winter MR; Nogueira CP; Larson PS; Finnemore EM; Dolan RW; Fuleihan N; Chakravarti A; Zietman A; Rosenberg CL
Clin Cancer Res; 1998 Nov; 4(11):2787-93. PubMed ID: 9829743
[TBL] [Abstract][Full Text] [Related]
22. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma.
Temam S; Casiraghi O; Lahaye JB; Bosq J; Zhou X; Julieron M; Mamelle G; Lee JJ; Mao L; Luboinski B; Benard J; Janot F
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4022-8. PubMed ID: 15217934
[TBL] [Abstract][Full Text] [Related]
23. Molecular support for field cancerization in the head and neck.
Lydiatt WM; Anderson PE; Bazzana T; Casale M; Hughes CJ; Huvos AG; Lydiatt DD; Schantz SP
Cancer; 1998 Apr; 82(7):1376-80. PubMed ID: 9529031
[TBL] [Abstract][Full Text] [Related]
24. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
25. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.
Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Kummer JA; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2004 Jun; 10(11):3607-13. PubMed ID: 15173066
[TBL] [Abstract][Full Text] [Related]
26. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
Leong PP; Rezai B; Koch WM; Reed A; Eisele D; Lee DJ; Sidransky D; Jen J; Westra WH
J Natl Cancer Inst; 1998 Jul; 90(13):972-7. PubMed ID: 9665144
[TBL] [Abstract][Full Text] [Related]
27. Simultaneously presenting head and neck and lung cancer: a diagnostic and treatment dilemma.
Kuriakose MA; Loree TR; Rubenfeld A; Anderson TM; Datta RV; Hill H; Rigual NR; Orner J; Singh A; Hicks WL
Laryngoscope; 2002 Jan; 112(1):120-3. PubMed ID: 11802049
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity of chromosome 9p21 and 7q31 is correlated with high incidence of recurrent tumor in head and neck squamous cell carcinoma.
Matsuura K; Shiga K; Yokoyama J; Saijo S; Miyagi T; Takasaka T
Anticancer Res; 1998; 18(1A):453-8. PubMed ID: 9568119
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis.
Huang J; Behrens C; Wistuba I; Gazdar AF; Jagirdar J
Ann Diagn Pathol; 2001 Dec; 5(6):321-9. PubMed ID: 11745069
[TBL] [Abstract][Full Text] [Related]
30. Karyotypic evolution and tumor progression in head and neck squamous cell carcinomas.
Jin Y; Jin C; Lv M; Tsao SW; Zhu J; Wennerberg J; Mertens F; Kwong YL
Cancer Genet Cytogenet; 2005 Jan; 156(1):1-7. PubMed ID: 15588849
[TBL] [Abstract][Full Text] [Related]
31. Loss of heterozygosity studies in squamous cell carcinomas of the head and neck.
Ransom DT; Leonard JH; Kearsley JH; Turbett GR; Heel K; Sosars V; Hayward NK; Bishop JF
Head Neck; 1996; 18(3):248-53. PubMed ID: 8860766
[TBL] [Abstract][Full Text] [Related]
32. Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer.
Takebayashi S; Hickson A; Ogawa T; Jung KY; Mineta H; Ueda Y; Grénman R; Fisher SG; Carey TE
Genes Chromosomes Cancer; 2004 Oct; 41(2):145-54. PubMed ID: 15287027
[TBL] [Abstract][Full Text] [Related]
33. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
[TBL] [Abstract][Full Text] [Related]
34. [Malignant multiple neoplasms in head and neck squamous cell carcinoma].
López Mollá C; Estellés Ferriol E; Carrasco Llatas M; Seijas Rosales T; Morales Suárez-Varela M; Dalmau Galofre J
Acta Otorrinolaringol Esp; 2008 Nov; 59(9):427-32. PubMed ID: 19080772
[TBL] [Abstract][Full Text] [Related]
35. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
Begum S; Gillison ML; Nicol TL; Westra WH
Clin Cancer Res; 2007 Feb; 13(4):1186-91. PubMed ID: 17317828
[TBL] [Abstract][Full Text] [Related]
36. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus.
Matsubara T; Yamada K; Nakagawa A
J Clin Oncol; 2003 Dec; 21(23):4336-41. PubMed ID: 14645422
[TBL] [Abstract][Full Text] [Related]
37. Comparative mutational profiling in the assessment of lung lesions: should it be the standard of care?
Moffatt-Bruce SD; Ross P; Leon ME; He G; Finkelstein SD; Vaida AM; Iwenofu OH; Frankel WL; Hitchcock CL
Ann Thorac Surg; 2010 Aug; 90(2):388-96. PubMed ID: 20667316
[TBL] [Abstract][Full Text] [Related]
38. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis.
Spafford MF; Koch WM; Reed AL; Califano JA; Xu LH; Eisenberger CF; Yip L; Leong PL; Wu L; Liu SX; Jerónimo C; Westra WH; Sidransky D
Clin Cancer Res; 2001 Mar; 7(3):607-12. PubMed ID: 11297256
[TBL] [Abstract][Full Text] [Related]
39. [Squamous cell carcinoma of the head and neck and pulmonary cancer. Report of 50 cases].
De Mones E; Hans S; Le Pimpec-Barthes F; Riquet M; Laccourreye O; Brasnu D
Ann Otolaryngol Chir Cervicofac; 1999 Dec; 116(6):341-50. PubMed ID: 10615525
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
